These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25370486)

  • 1. The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.
    Respondek G; Stamelou M; Kurz C; Ferguson LW; Rajput A; Chiu WZ; van Swieten JC; Troakes C; Al Sarraj S; Gelpi E; Gaig C; Tolosa E; Oertel WH; Giese A; Roeber S; Arzberger T; Wagenpfeil S; Höglinger GU;
    Mov Disord; 2014 Dec; 29(14):1758-66. PubMed ID: 25370486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.
    Kurz C; Ebersbach G; Respondek G; Giese A; Arzberger T; Höglinger GU
    Acta Neuropathol Commun; 2016 Nov; 4(1):120. PubMed ID: 27842578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of PSP phenotypes with survival: A brain-bank study.
    Guasp M; Molina-Porcel L; Painous C; Caballol N; Camara A; Perez-Soriano A; Sánchez-Gómez A; Garrido A; Muñoz E; Marti MJ; Valldeoriola F; Grau O; Gelpí E; Respondek G; Höglinger GH; Compta Y
    Parkinsonism Relat Disord; 2021 Mar; 84():77-81. PubMed ID: 33581485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalamic hypoperfusion in early stage of progressive supranuclear palsy (Richardson's syndrome): report of an autopsy-confirmed case.
    Kobayashi Z; Akaza M; Ishihara S; Tomimitsu H; Inadome Y; Arai T; Akiyama H; Shintani S
    J Neurol Sci; 2013 Dec; 335(1-2):224-7. PubMed ID: 24075472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
    O'Sullivan SS; Massey LA; Williams DR; Silveira-Moriyama L; Kempster PA; Holton JL; Revesz T; Lees AJ
    Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.
    Campagnolo M; Weis L; Fogliano C; Cianci V; Garon M; Fiorenzato E; Carecchio M; Ferreri F; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2023 Feb; 130(2):97-109. PubMed ID: 36701008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vestibular symptoms as the presenting feature of progressive supranuclear palsy.
    Haggstrom L; Brew B; Sutton I; Tisch S
    J Clin Neurosci; 2018 Apr; 50():74-76. PubMed ID: 29398194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.
    Lopez G; Bayulkem K; Hallett M
    Acta Neurol Scand; 2016 Oct; 134(4):242-9. PubMed ID: 27070344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which ante mortem clinical features predict progressive supranuclear palsy pathology?
    Respondek G; Kurz C; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Giese A; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Whitwell JL; Antonini A; Bhatia KP; Bordelon Y; Corvol JC; Colosimo C; Dodel R; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris H; Nestor P; Oertel WH; Rabinovici GD; Rowe JB; van Eimeren T; Wenning GK; Boxer A; Golbe LI; Litvan I; Stamelou M; Höglinger GU;
    Mov Disord; 2017 Jul; 32(7):995-1005. PubMed ID: 28500752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive supranuclear palsy.
    Giagkou N; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.
    Srulijes K; Mallien G; Bauer S; Dietzel E; Gröger A; Ebersbach G; Berg D; Maetzler W
    J Neural Transm (Vienna); 2011 Aug; 118(8):1191-7. PubMed ID: 21207078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
    Shoeibi A; Litvan I; Tolosa E; Ser TD; Lee E;
    Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants.
    Street D; Malpetti M; Rittman T; Ghosh BCP; Murley AG; Coyle-Gilchrist I; Passamonti L; Rowe JB
    Brain Commun; 2021; 3(3):fcab206. PubMed ID: 34541533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A; Pagonabarraga J; Martínez-Horta S; Busteed L; Pascual-Sedano B; Illán-Gala I; Marin-Lahoz J; Aracil-Bolaños I; Pérez-Pérez J; Sampedro F; Bejr-Kasem H; Kulisevsky J
    J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
    Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
    Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.